Literature DB >> 11277855

Possible applications for dopaminergic agents following traumatic brain injury: part 2.

R D Zafonte1, J Lexell, N Cullen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11277855     DOI： 10.1097/00001199-200102000-00014

Source DB:  PubMed          Journal:  J Head Trauma Rehabil        ISSN： 0885-9701            Impact factor:   2.710


× No keyword cloud information.
  3 in total

1.  Dopamine D2-receptor-mediated increase in vascular and endothelial NOS activity ameliorates cerebral vasospasm after subarachnoid hemorrhage in vitro.

Authors:  Gail J Pyne-Geithman; Danielle N Caudell; Matthew Cooper; Joseph F Clark; Lori A Shutter
Journal:  Neurocrit Care       Date:  2008-09-20       Impact factor: 3.210

2.  Clinical comparison of 99mTc exametazime and 123I Ioflupane SPECT in patients with chronic mild traumatic brain injury.

Authors:  Andrew B Newberg; Mijail Serruya; Andrew Gepty; Charles Intenzo; Todd Lewis; Daniel Amen; David S Russell; Nancy Wintering
Journal:  PLoS One       Date:  2014-01-24       Impact factor: 3.240

Review 3.  Amantadine: reappraisal of the timeless diamond-target updates and novel therapeutic potentials.

Authors:  Wojciech Danysz; Andrzej Dekundy; Astrid Scheschonka; Peter Riederer
Journal:  J Neural Transm (Vienna)       Date:  2021-02-23       Impact factor: 3.575
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.